Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?: a Gynecologic Oncology Group ancillary data analysis.


BACKGROUND This study evaluated whether progression-free interval (PFI) following primary chemotherapy (PCT) was predictive of overall survival (OS) after second-line chemotherapy in advanced/recurrent endometrial cancer (EC). METHODS This is a pooled analysis of patients who recurred after PCT and were treated with second-line chemotherapy on Gynecologic… (More)
DOI: 10.1002/cncr.25480


  • Presentations referencing similar topics